BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramasamy P, Larkin AM, Linge A, Tiernan D, McAree F, Horgan N, Moriarty P, Beatty S, Murphy CC, Clynes M, Kennedy S, Meleady P. PRDX3 is associated with metastasis and poor survival in uveal melanoma. J Clin Pathol 2020;73:408-12. [PMID: 31771972 DOI: 10.1136/jclinpath-2019-206173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Carpenter EL, Becker AL, Indra AK. NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation. Cancers (Basel) 2022;14:1531. [PMID: 35326683 DOI: 10.3390/cancers14061531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Carvalho LAC, Queijo RG, Baccaro ALB, Siena ÁDD, Silva WA, Rodrigues T, Maria-engler SS. Redox-Related Proteins in Melanoma Progression. Antioxidants 2022;11:438. [DOI: 10.3390/antiox11030438] [Reference Citation Analysis]
3 Lamas NJ, Martel A, Nahon-Estève S, Goffinet S, Macocco A, Bertolotto C, Lassalle S, Hofman P. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers (Basel) 2021;14:96. [PMID: 35008260 DOI: 10.3390/cancers14010096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gajdzis M, Kaczmarek R, Gajdzis P. Novel Prognostic Immunohistochemical Markers in Uveal Melanoma-Literature Review. Cancers (Basel) 2021;13:4031. [PMID: 34439182 DOI: 10.3390/cancers13164031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shen Y, Xu H, Li L, Lu Y, Zhang M, Huang X, Tang X. Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma. Cancer Manag Res 2021;13:5725-37. [PMID: 34290530 DOI: 10.2147/CMAR.S319048] [Reference Citation Analysis]
6 Jaganjac M, Milkovic L, Sunjic SB, Zarkovic N. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies. Antioxidants (Basel) 2020;9:E1151. [PMID: 33228209 DOI: 10.3390/antiox9111151] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
7 Yu R, Yao J, Ren Y. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma. J Cell Mol Med 2020;24:10177-88. [PMID: 32729669 DOI: 10.1111/jcmm.15629] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]